The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on August 11, 2026

4 hours ago

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

4 hours ago

Spectral AI Announces 2026 Second Quarter Financial Results

Indeterminate GlobeNewswire

4 hours ago

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

Indeterminate GlobeNewswire

4 hours ago

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

4 hours ago

Mobia Medical Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing

Indeterminate GlobeNewswire

4 hours ago

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

4 hours ago

Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Indeterminate GlobeNewswire

4 hours ago

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire

4 hours ago

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Indeterminate GlobeNewswire

4 hours ago

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire

4 hours ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

4 hours ago

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

4 hours ago

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Indeterminate GlobeNewswire

4 hours ago

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

4 hours ago

ASHA Names 2026 Media Champion Award Recipients

Indeterminate GlobeNewswire

4 hours ago

Rampart Withdraws Appeal of USPTO’s Invalidation Decision

Indeterminate GlobeNewswire

4 hours ago

New Drug to Treat Pancreatic Cancer May Be a “Game Changer” as 10 Intermountain Hospitals Join National Initiative

Indeterminate GlobeNewswire

4 hours ago

Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results

Indeterminate GlobeNewswire

4 hours ago

Five Years of Unprecedented Growth: TimelyCare Redefines Student Well-Being

Indeterminate GlobeNewswire